Various systemic therapies for psoriasis either reduced, slightly increased or had no effect on risk for major adverse ...

Researchers have identified in a new study that increased serum 25-hydroxyvitamin D (25(OH)D) is linked with lower risks of ...

Discover a study in which researchers examined three international cohorts of patients with moderate-to-severe psoriasis ...

About 1 in 3 people with psoriasis who achieved clear skin with biologic drugs still had underlying inflammation that may ...

Psoriasis, with its systemic inflammatory nature, high risk of cardiovascular disease, and frequent use of biologic drugs, could provide a valuable framework for studying residual inflammation.

There are several reasons psoriasis may increase the risk of heart disease. “Psoriasis shares some common factors with heart disease, including genetic relationships”, says Joel Gelfand ...

A new international study has shed light on the hidden dangers of psoriasis, revealing that this chronic skin condition may carry greater health risks than previously understood. Researchers have ...

New research shows that in patients with psoriasis, even though their skin responds well to treatment with biologics ...

Psoriasis, with its systemic inflammatory nature, high risk of cardiovascular disease, and frequent use of biologic drugs, could provide a valuable framework for studying residual inflammation. The ...

For patients with psoriasis receiving biologic therapy, residual inflammation (RI), defined as increased inflammatory markers in blood, characterized by high-sensitivity C-reactive protein, despite ...

BMY's banks on label expansion of drugs like Sotyktu and Opdivo to boost sales in the wake of generic competition for legacy ...